← Eichor
Study identifier: NCT07716059 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Legume Flour Particle Size and Metabolic Responses to Bread

Condition: Type 2 Diabetes  ·  Sponsor: Harokopio University

PhaseNA
Planned participants35
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The aim of the study is to investigate the effect of partial replacement of wheat flour by legume flour of different particle sizes on postprandial glucose responses and appetite sensations in healthy subjects and patients with type 2 diabetes. Subjects will consume a portion of bread enriched with legume flours yielding 50 g of available carbohydrates as breakfast meal. To investigate the effect of the bread on glycemic response, a continuous glucose monitoring system (CGM) will be used. After an 180-min period, subjects will be given a second meal and glycemic response will be monitored for another 180 min. During the trial subjects must fill appropriate visual analogue scales regarding appetite sensations.

This description comes directly from the study's public registry record.

Talk to the study team

Maria Christina Kanata, MSc  ·  +306937900141  ·  mckanata@hua.gr

Amalia E Yanni, PhD  ·  ayanni@hua.gr

Always discuss trial participation with your own doctor first.

Locations (2)

Harokopio UniversityAthens, Attica, GreeceRecruiting
1st Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 15772 Athens, GreeceAthens, Attica, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07716059